| Pharmaceutical active ingredients: |
| Pramipexole Dihydrochloride |
| Available forms, composition and doses of Mirapex: |
| Tablets; Oral; Pramipexole Dihydrochloride 0.125 mgTablets; Oral; Pramipexole Dihydrochloride 0.25 mgTablets; Oral; Pramipexole Dihydrochloride 0.5 mgTablets; Oral; Pramipexole Dihydrochloride 0.75 mgTablets; Oral; Pramipexole Dihydrochloride 1 mgTablets; Oral; Pramipexole Dihydrochloride 1.25 mgTablets; Oral; Pramipexole Dihydrochloride 1.5 mg |
| Mirapex medical category: |
| Human:Antiparkinsonian drugsCentral nervous system agentsNonergot-derivative dopamine receptor agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BC05 - Pramipexole |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer IngelheimPfizerZuellig Pharma |
| Related documents and information about Mirapex: |
| Mirapex prescribing information (PDF)Mirapex ER prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Miramind | Mirtazapine | Torrent Pharmaceuticals |
| Miramycin | Gentamicin Sulfate | Atlantic Laboratories; Agencia Lei Va Hong |
| Miranax | Naproxen Sodium | Roche; GlaxoSmithKline; Grunenthal |
| Miranova | Ethinyl Estradiol; Levonorgestrel | Bayer Schering Pharma |
| Mirantal | Medrysone; Neomycin Sulfate; Phenylephrine Hydrochloride; Zinc Sulfate | Novartis |
| Mirapex ER | Pramipexole Dihydrochloride | Boehringer Ingelheim |
| Mirapexin | Pramipexole Dihydrochloride Monohydrate | Boehringer Ingelheim; Pfizer |
| Mirapront | Phentermine Resin Complex | Pfizer |
| Mirapront N | Cathine Polystyroldivinylbenzol-Sulfonic Acid | Pfizer; Edward Keller; Summit; Zuellig Pharma |
| Miraqule | Ubidecarenone | Alchem Phytoceuticals |